Osiris Therapeutics Inc Q3 2018 Big Money Sentiment Better Than Expected, now at 27

“Big money” Positions

“Big money sentiment for Osiris Therapeutics Inc (NASDAQ:OSIR) in 2018 Q3 increased to 27, SEC filings reveal. That’s up 27.00, from 2018Q2’s 0. 27 institutional investors increased or started new stock positions, while 1 reduced and sold their positions in Osiris Therapeutics Inc so the sentiment increased. These funds own 5.15 million shares, that’s up from 11,982 shares in 2018Q2. Funds holding Osiris Therapeutics Inc in top 10 was flat from 0 to 0 for the same number . In total 1 funds closed positions, 0 reduced and 0 increased. Also 27 funds bought new Osiris Therapeutics Inc stakes.

Most Osiris Therapeutics Inc Shareholders

Deltec Asset Management Llc owns 50,000 shares in Osiris Therapeutics Inc as of 2018 Q3. Osiris Therapeutics Inc’s shareholder Gabelli Funds Llc owns 460,389 shares as of 2018 Q3. Caprock Group Inc. reported 10,000 shares. The New York-based fund Gamco Investors Inc. Et Al have invested about 0.01% of the investment professional’s stock portfolio in Osiris Therapeutics Inc. The New York-based fund Horizon Kinetics Llc holds 19,000 shares or 0.01% of their fund portfolio.

Osiris Therapeutics, Inc. researches, develops, makes, markets, and distributes regenerative medicine products in the United States.The firm is worth $455.05 million. The Company’s products include Grafix and Stravix for treating chronic wounds of diabetic foot ulcers, venous leg ulcers, pressure ulcers, arterial ulcers, and severe burns, as well as surgical and trauma wounds; BIO4 for bone repair and regeneration in spine, trauma, extremity, cranial, and foot and ankle surgeries; and Cartiform for treating articular cartilage lesions in the knee and other joints.74.46 is the P/E ratio. The firm also develops and markets Menvivo for the repair of meniscus; and TruSkin for treating chronic wounds.

OSIR reached $13.18 during the last trading session after $0.18 change.Osiris Therapeutics, Inc. has volume of 13,345 shares. Since January 9, 2018 OSIR has risen 144.91% and is uptrending. OSIR outperformed by 144.91% the S&P500.

Renaissance Technologies Limited Liability owns 31,640 shs or 0% of their US capital. Deutsche Savings Bank Ag stated it has 0% in Osiris Therapeutics, Inc. (NASDAQ:OSIR). Sg Americas Secs Ltd Llc holds 12,693 shs. Wilbanks Smith And Thomas Asset Mngmt Ltd Limited Liability Company owns 5,500 shs. Royal Comml Bank Of Canada accumulated 3,000 shs. Blackrock has 1,000 shs for 0% of their capital. Susquehanna International Group Llp holds 137,298 shs or 0% of its capital. Qs Investors holds 0.01% or 105,759 shs in its capital. Manufacturers Life Insur The reported 0.01% of its capital in Osiris Therapeutics, Inc. (NASDAQ:OSIR). Geode Cap Mgmt invested in 0% or 107,874 shs. Vanguard Group Incorporated Inc holds 0% or 715,016 shs in its capital. Fincl Bank Of America Corp De has 4,914 shs for 0% of their capital. 23,383 were accumulated by Jpmorgan Chase And. Horizon Kinetics Limited Liability Company holds 0.01% or 19,000 shs in its capital. Deltec Asset Management Ltd Limited Liability Company accumulated 50,000 shs.

For more Osiris Therapeutics, Inc. (NASDAQ:OSIR) news published briefly go to: Benzinga.com, Seekingalpha.com, Seekingalpha.com, Businesswire.com or Seekingalpha.com. The titles are as follows: “Daily Biotech Pulse: No Anxiety For Biohaven (NYSE:BHVN), Strongbridge’s About-Face (NASDAQ:SBBP), Bristol-Myers Squibb’s FDA Wait (NYSE:BMY) – Benzinga” published on August 16, 2018, “Legal Trouble May Be Coming For Osiris’ Sales Executives – Seeking Alpha” on May 08, 2015, “Cell Therapy Crossing Into Babylon? – Seeking Alpha” with a publish date: November 15, 2018, “Osiris Announces 100% Medicare Coverage for Grafix – Business Wire” and the last “Osiris Therapeutics: Solutions To Challenging Problems – Seeking Alpha” with publication date: January 02, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.